David Malcom Rodman

CIK 1672659 · Chief Medical Officer · last filed 2026-05-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.51M

Companies

2

Total Filings

55

Lifetime Open-Market Net

-$18.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MLYS Chief Medical Officer 63,860 $23.62 $1.51M -$18.73M 51 2026-05-19
ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted Exec Vice President and CMO 11,368 -$89.2K 4 2017-01-05

Recent Filings · Page 3 of 6

55 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-16 MLYS Mixed −5,018 -$159.1K EDGAR
2025-05-15 MLYS Sell (S) −11,366 -$173.8K EDGAR
2025-05-13 MLYS Exer (M) +6,349 $6.9K EDGAR
2025-04-15 MLYS Mixed −5,018 -$158.3K EDGAR
2025-04-03 MLYS Mixed −54,165 -$877.3K EDGAR
2025-03-13 MLYS Exer (M) +6,349 $6.9K EDGAR
2025-02-24 MLYS Grant (A) $0 EDGAR
2025-02-13 MLYS Exer (M) +6,348 $6.9K EDGAR
2025-01-15 MLYS Exer (M) +11,367 $9.6K EDGAR
2024-12-13 MLYS Exer (M) +5,017 $2.7K EDGAR
Showing 2130 of 55
Page 3 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.